GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Disclosure Under Clause 30

GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Mid-range Performer

2724.0000 -28.20 (-1.02%)

NSE Sep 03, 2025 12:38 PM

41.80% Gain from 52W Low

Volume: 63,513

GlaxoSmithKline Pharmaceuticals Ltd.

03 Sep 2024

2724.00

-1.02%

Company Update

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Disclosure Under Clause 30

BSE India

Disclosure under clause 30

More from GlaxoSmithKline Pharmaceuticals Ltd.

Recommended

Market trades higher, Netweb Tech bags a Rs 1,734 crore order under the IndiaAI Mission

Trendlyne Marketwatch | 03 Sep 2025, 12:41PM

Five stocks to buy from analysts this week - September 2, 2025

The Baseline | 02 Sep 2025, 06:04PM

IPO activity stays steady with Amanta and seven SME issues opening this week

| 02 Sep 2025, 11:38AM